also reported that the breadth and magnitude of T cell immunity is greater in more severe cases of COVID-19, but at the same time the proportion of activated and proliferating CD8+ T cells is increased in patients with mild COVID-19 (20, 33). The gene discussed is CD8A; the disease is COVID-19.